Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia

References

Page 1

	Year	Citations
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge William T. Friedewald, Robert I. Levy, Donald S. Fredrickson Clinical Chemistry Lipid AnalysisHyperlipidemiaDirect ProcedureMetabolic SyndromeBody Composition	1972	32.1K
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Anders Olsson, John J.V. McMurray, G Thorgeirsson, The Lancet Cardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemiaPreventive Cardiology	1994	8.5K
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, New England Journal of Medicine	1996	7.5K
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia James Shepherd, Stuart M. Cobbe, Ian Ford, New England Journal of Medicine	1995	7.5K
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial The Lancet Lipid DisorderCardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemia	2002	7K
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats Saritha Marella, Dilip Rajasekhar Maddirela, Kameswara Rao Badri, Cellular Physiology and Biochemistry	2015	5.9K
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels John R. Downs, Michael Clearfield, Stephen E. Weis, JAMA	1998	5.3K
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA J Ames S Hepherd, S Tuart M. C Obbe, I An F Ord, Metabolic SyndromeCardiovascular EpidemiologyCardiovascular DiseaseCholesterol Lev- ElAtherosclerosis	1995	3.5K
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) SCANDINAVIANSIMVASTATINSURVIVAL The Lancet Cardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemiaPreventive Cardiology	1994	2.4K
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials The Lancet Percutaneous Coronary InterventionHigh-risk GroupsPreventive MedicineCardiovascular EpidemiologyCardiovascular Disease	1996	1.6K

Page 1